• No results found

Metformin inhibits 17β-estradiol-induced epithelial-to- mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells

N/A
N/A
Protected

Academic year: 2020

Share "Metformin inhibits 17β-estradiol-induced epithelial-to- mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells"

Copied!
17
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1: Metformin inhibits E2-induced proliferation, migration, and invasion in Ishikawa cells
Figure 2: Metformin inhibits E2-induced proliferation and migration in KLE cells. A. KLE cells were treated with metformin (0, 1, 10, and 20 mM) (left) and E2 with or without metformin (right), cell numbers were measured by CCK-8 assays at indicated times
Figure 3: Metformin antagonizes 17β-estradiol-induced anti-apoptosis effect in endometrial adenocarcinoma cells
Figure 4: Metformin reverses 17β-estradiol-induced EMT in Ishikawa cells involving βKlotho expression, ERK1/2 and AMPKα signaling pathways
+7

References

Related documents

The expression of epithelial phenotype marker protein E-cadherin was gradually decreased, and the expression of the intersti- tial phenotype marker protein N-cadherin was gradually

Our results revealed that overexpression of PAK4 further decreased E-cadherin protein expression and increased fibronectin and vimentin protein expression induced by TGF-β1 in

B: In 231-siRNA-IMP3 cells, real-time PCR analyses showed increased E-cadherin and decreased Slug and vimentin in mRNA levels, compared to the control cells (231-mock and 231-nc)..

The expression of E-cadherin was increased and the expression of N-cadherin was decreased at both mRNA and protein level in the HCC cells transfected with pRK5-A20 compared

Furthermore, Western blotting analysis demonstrated that PNUTS inhibition increased the expression levels of vimentin and N-cadherin while suppressing E-cadherin expression in

Our results also showed that metformin significantly suppressed self-renewal capacity of glioblastoma stem cells (GSCs), and expression of stem cell markers Bmi1, Sox2 and

Overexpression of miR-145 significantly decreased the expression level of FSCN1 protein in docetaxel-resistant LAD cells, whereas downregulation of miR145 led to the

Meanwhile, EMT was reversed in SKOV3 and 3AO cells by downregulation of FSCN1, as shown by increased expression of E-cadherin, decreased expression of N-cadherin and vimentin